Vietnam Covid-19 vaccine producer valued at $220 mln

Update: 20:53 | 09/12/2020

Covid-19 vaccine producer Nanogen Pharmaceutical Biotechnology JSC has been evaluated higher than major pharma peers at VND5.1 trillion ($220 million).

The company, one of three Covid-19 vaccine developers in the country, is set to be the first to conduct human trials in the country. It saw its foreign ownership ratio increase by 9.4 percentage points to 25.68 earlier last year after receiving an investment from a group of South Korean companies.

Vietnam, Covid-19 vaccine producer, Nanogen Pharmaceutical Biotechnology, vaccine developers, human trials, Asia Pacific region

Bottles containing Covid-19 vaccine produced by Nanogen.

One of the investors was KIS Vietnam Securities Corporation, which said in its financial statement that it had spent nearly VND11.6 billion on purchasing 162,500 shares of Nanogen, giving the company a valuation of VND5.1 trillion.

This was higher than the current market cap of major pharmaceutical Vietnamese companies like Imexpharm (VND3.67 trillion) and Traphaco (VND2.85 trillion).

Nanogen, established in 1997, says on its website that it is a leading researcher and developer of active biopharmaceutical ingredients and specific therapeutic injections in the Asia Pacific region.

It has its chairman Ho Nhan, who grew up in New York and has a PhD in biotechnology. Nhan had accumulated 20 years of experience in biotech research abroad before establishing a company in Vietnam.

Nanogen made headlines in 2010 when Switzerland-headquartered pharmaceutical firm Roche accused it of violating intellectual rights in the production of medicines to treat hepatitis B patients.

Nanogen’s injection cost one-third of the imported medicine at the time, and the company asserted it had not committed any intellectual rights violations.

Australia supports Vietnam and other countries to access Covid-19 vaccine
The Australian Government has pledged to provide AUD500 million for countries in Southeast Asia and the Pacific to access safe and effective Covid-19 vaccines, the Australian Embassy in Vietnam announced November 6.
Vietnam may begin human trials of Covid-19 vaccine this month
A Vietnamese Covid-19 vaccine may enter human trials as early as this month, a health ministry official said Tuesday.
Vietnam starts Covid-19 vaccine trials on monkeys
The State-owned Company for Vaccine and Biological Production No. 1 (VABIOTECH) has started trials of its experimental Covid-19 vaccine on rhesus macaque (Macaca mulatta) on Reu Island off the northern province of Quang Ninh.
Vietnam speeds up Covid-19 vaccine research
As one of 42 countries around the world that can produce vaccines, Vietnam is speeding up its vaccine research to soon finalise a "made in Vietnam" Covid-19 vaccine for all Vietnamese people.

Source: VnExpress

Bình luận mới vừa được thêm vào. Click để xem
Mới nhấtHay nhấtXếp theo: